South Dakota Investment Council Regenxbio Inc. Transaction History

South Dakota Investment Council

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$30.19 - $40.28 $81,211 - $108,353	-2,690 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$29.09 - $45.68 $1.28 Million - $2.01 Million	-44,000 Reduced 94.24%	2,690 $113,000
Q1 2021 May 13, 2021	BUY	$33.61 - $49.95 $1.39 Million - $2.07 Million	41,490 Added 797.88%	46,690 $1.59 Million
Q3 2019 Nov 13, 2019	BUY	$31.84 - $50.88 $50,944 - $81,408	1,600 Added 44.44%	5,200 $185,000
Q3 2018 Nov 14, 2018	BUY	$65.0 - $82.15 $234,000 - $295,740	3,600 New	3,600 $272,000

191

45.4M

184K

56.7K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $314M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.